Startup Headed by Ex-Biogen Japan Chief Working to Develop New Alzheimer’s Drugs Using Photocatalysts

Vermillion Therapeutics CEO Shinichi Torii Shinichi Torii, former Biogen Japan president, has established a drug discovery startup that is conducting R&D for Alzheimer’s disease (AD) treatments based on photocatalysts. Under a licensing pact with the University of Tokyo, his company...read more